Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Minor hypoglycemia occurred more frequently with liraglutide, but there was no major hypoglycemia
Some people may also experience adverse effects like mild diarrhea, itching, or a swelling sensation in the body
Xuan C, Zhang BB, Yang T, et al
It comes after June 2025 policy changes that allow any doctor, not necessarily an expert, to prescribe these drugs
However Lillys demonstration that a GIP/GLP-1 receptor co-agonist (tirzepatide) has superior efficacy compared to selective GLP-1 receptor agonists, has renewed interest in the first incretin. Lilly rolled out their SURPASS trials to position their agent amongst existing diabetes medications and GLP-1 agonists
US$ 21.41
US$ 29.10
US$ 26.86
US$ 20.88
